(PITTSBURGH)Drugmaker Mylan Inc. said Thursday its third-quarter profit grew 15 percent due to sales from the Merck KGaA generic business, which it bought last year, and deferred revenue from ...READ MORE

Among the earnings stories for Tuesday, Oct. 21, from AP Financial News: WATERBURY, Conn. (AP)--Webster Financial Corp. on Tuesday posted a third-quarter loss as it saw the number ...READ MORE

Among the earnings projection stories for Tuesday, Oct. 21, from AP Financial News: PITTSBURGH (AP)--Laser component maker II-VI Inc. raised its fiscal 2009 profit forecast on Tues...READ MORE

(NEW YORK)Drug maker Forest Laboratories Inc. on Tuesday raised its fiscal 2009 profit outlook, expecting a lower tax rate. The New York-based company now expects an adjusted profit of $3.30...READ MORE

(NEW YORK)Drug maker Forest Laboratories Inc. said Tuesday that stronger sales of its Alzheimer's disease treatment Namenda helped lift its second-quarter profit 8 percent.READ MORE

(NEW YORK)Forest Laboratories Inc. and Cypress Bioscience Inc. said Monday the Food and Drug Administration will delay reviewing their application for a prospective fibromylagia drug, but ha...READ MORE

(WASHINGTON)Shares of Cypress Bioscience jumped Thursday as the deadline for an approval decision on the company's lead product draws closer. The Food and Drug Administration is scheduled to m...READ MORE